At a glance
ClinicalIndex Comparison RecordN/ACompleted· 2,623 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Prognostic and Diagnostic Value of Ferritin in Critically Ill Patients With Special Focus on Underlying Hemophagocytic Lymphohistiocytosis
In Brief
An observational study for Hemophagocytic Lymphohistiocytosis (HLH) and 2 related conditions. Completed, enrolled 2,623 participants.
Detailed Summary
Retrospective analysis of ferritin, outcome and HLH-criteria in critically ill patients.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHemophagocytic Lymphohistiocytosis (HLH), Macrophage Activation Syndrome (MAS), Hemophagocytic Syndromes
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2000
First PostedAug 2016
Primary CompletionAug 2018
TodayJul 2026
First PostedAug 4, 2016
Enrollment StartJan 1, 2000
Primary CompletionAug 1, 2018
TodayJul 2, 2026
Enrollment to primary: 18.6 yearsPosted 9.9 years ago